Dysregulated Class I histone deacetylases are indicators of poor prognosis in multiple myeloma

Sridurga Mithraprabhu, Anna Kalff, Annie Chow, +2

Epigenetics

Hematological MalignancyTumor BiologyChromatinClass IiHistone Deacetylases +12

The t(4;14) translocation and FGFR3 overexpression in multiple myeloma: prognostic implications and current clinical strategies

Anna Kalff, Andrew Spencer

Blood Cancer Journal

Mixed-phenotype Acute LeukemiaImmunologyPathologyImmunotherapyTumor Biology +15

Circulating tumour DNA analysis demonstrates spatial mutational heterogeneity that coincides with disease relapse in myeloma

Sridurga Mithraprabhu, Tiffany Khong, Malarmathy Ramachandran, +11

Leukemia

Hematological MalignancyDisease RelapseOncologySomatic VariantTumor Heterogeneity +10

Monitoring tumour burden and therapeutic response through analysis of circulating tumour DNA and extracellular RNA in multiple myeloma patients

Sridurga Mithraprabhu, Rachel Morley, Tiffany Khong, +10

Leukemia

Hematological MalignancyOncologyTumour DnaHealth SciencesNucleic Acid Biomarkers +12

Phase 1, First-in-Human Study of MEDI2228, a BCMA-Targeted ADC in Patients with Relapsed/Refractory Multiple Myeloma

Shaji Kumar, Magdalini Migkou, Manisha Bhutani, +17

Blood

The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adults

Anna Kalff, Claire Dowsing, Andrew Grigg

British Journal of Haematology

ImmunohematologyHeart FailureThirteen Adult PatientsThrombosisRegular Ecp +15

Central nervous system multiple myeloma – potential roles for intrathecal therapy and measurement of cerebrospinal fluid light chains

Denise Lee, Anna Kalff, Michael Löw, +6

British Journal of Haematology

Liquid biopsies for liquid tumors: emerging potential of circulating free nucleic acid evaluation for the management of hematologic malignancies

Sridurga Mithraprabhu, Anna Kalff, Andrew Spencer, +3

Cancer Biology and Medicine

Free Nucleic AcidsPathologyLiquid TumorsLiquid BiopsiesNucleic Acid Biomarkers +19

Bisphosphonate guidelines for treatment and prevention of myeloma bone disease

Oi Lin Lee, Noemi Horvath, Cindy Lee, +20

Internal Medicine Journal

Bone DiseaseTranslational MedicineAdverse EventsBone HealthHematology +12

Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study)

Anna Kalff, Tiffany Khong, Sridurga Mithraprabhu, +9

Leukemia & lymphoma/Leukemia and lymphoma

Relapsed/refractory MmPharmacotherapyMetronomic ChemotherapyLenalidomide-refractory Multiple MyelomaPre-clinical Pharmacology +17